Novel mouse mammary cell lines for in vivo bioluminescence imaging (BLI) of bone metastasis

Biological Procedures Online

Volumn 14, Issue 1, 2012, Pages

  Bolin, Celeste ^a   Sutherland, Caleb ^a,b   Tawara, Ken ^a   Moselhy, Jim ^a   Jorcyk, Cheryl L ^a  

^a BOISE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

4 T1 cells; 4 T1.2 cells; Bone metastasis; Breast cancer; in vivo imaging; Mammary cancer; Osteolysis; Syngeneic Balb c model

Indexed keywords

LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BONE METASTASIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF DETECTION; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOLYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINE METASTASIS; TUMOR CELL LINE; TUMOR LOCALIZATION; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

EID: 84866428259     PISSN: None     EISSN: 14809222     Source Type: Journal    
DOI: 10.1186/1480-9222-14-6     Document Type: Article

References (17)

1. Breast cancer metastasis: Markers and models. Weigelt B, Peterse JL, van't Veer LJ, Nat Rev Cancer 2005 5 8 591 602 10.1038/nrc1670 16056258 (Pubitemid 41081385)
2. Skeletal complications of malignancy. Coleman RE, Cancer 1997 80 8 1588 1594 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G 9362426 (Pubitemid 27444031)
3. Clinical course and prognostic factors following bone recurrence from breast cancer. Coleman RE, Smith P, Rubens RD, Br J Cancer 1998 77 2 336 340 10.1038/bjc.1998.52 9461007 (Pubitemid 28029553)
4. Metastatic Behavior of Breast Cancer Subtypes. Kennecke H, Yerushalmi R, Woods R, Cheang MCU, Voduc D, Speers CH, Nielsen TO, Gelmon K, J Clin Oncol 2010 28 20 3271 3277 10.1200/JCO.2009.25.9820 20498394
5. From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies. Ottewell PD, Coleman RE, Holen I, Breast Cancer Res Treat 2006 96 2 101 113 10.1007/s10549-005-9067-x 16319986
6. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A, Nature 1992 356 6366 215 221 10.1038/356215a0 1552940
7. Mouse models of breast cancer metastasis. Fantozzi A, Christofori G, Breast Cancer Research 2006 8 4 212 223 10.1186/bcr1530 16887003 (Pubitemid 46442933)
8. Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Montel V, Mose ES, Tarin D, Int J Cancer 2006 119 2 251 263 10.1002/ijc.21757 16482564
9. Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines. Clarke R, Breast Cancer Res Treat 1996 39 1 69 86 10.1007/BF01806079 8738607 (Pubitemid 26136505)
10. A novel orthotopic model of breast cancer metastasis to bone. Lelekakis M, Moseley J, Martin T, Hards D, Williams E, Ho P, Lowen D, Javni J, Miller F, Slavin J, et al. Clinical & Experimental Metastasis 1999 17 2 163 170 10.1023/A:1006689719505 23071977 (Pubitemid 29335443)
11. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Eckhardt BL, Parker BS, van Laar RK, Restall CM, Natoli AL, Tavaria MD, Stanley KL, Sloan EK, Moseley JM, Anderson RL, Mol Cancer Res 2005 3 1 1 13 15671244 (Pubitemid 40189591)
12. Mouse 4 T1 Breast Tumor Model. Pulaski BA, Ostrand-Rosenberg S, In: Current Protocols in Immunology edn.: John Wiley & Sons, Inc. 2001
13. Of Mice and (Wo)men: Mouse Models of Breast Cancer Metastasis to Bone. Goldstein RH, Weinberg RA, Rosenblatt M, J Bone Miner Res 2010 25 3 431 436 10.1002/jbmr.68 20200984
14. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. Kim JB, Urban K, Cochran E, Lee S, Ang A, Rice B, Bata A, Campbell K, Coffee R, Gorodinsky A, et al. PLoS One 2010 5 2 9364 10.1371/journal.pone. 0009364 20186331
15. 2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo. Cicek M, Iwaniec UT, Goblirsch MJ, Vrabel A, Ruan M, Clohisy DR, Turner RR, Oursler MJ, Cancer Res 2007 67 21 10106 10111 10.1158/0008-5472.CAN-07-1362 17974950 (Pubitemid 350070780)
16. Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone. Zwolak P, Jasinski P, Terai K, Gallus NJ, Ericson ME, Clohisy DR, Dudek AZ, Eur J Cancer 2008 44 16 2506 2517 10.1016/j.ejca.2008.07.011 18723339
17. Novel cytosine deaminase fusion gene enhances the effect of radiation on breast cancer in bone by reducing tumor burden, osteolysis, and skeletal fracture. Goblirsch M, Zwolak P, Ramnaraine ML, Pan W, Lynch C, Alaei P, Clohisy DR, Clin Cancer Res 2006 12 10 3168 3176 10.1158/1078-0432.CCR-05-2729 16707617 (Pubitemid 43837366)